Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$8.02 - $8.67 $360 - $390
-45 Reduced 0.42%
10,787 $91,000
Q4 2023

Jan 25, 2024

SELL
$7.78 - $8.62 $54 - $60
-7 Reduced 0.06%
10,832 $89,000
Q3 2023

Oct 23, 2023

SELL
$7.85 - $8.94 $46,024 - $52,415
-5,863 Reduced 35.1%
10,839 $90,000
Q2 2023

Jul 21, 2023

BUY
$8.04 - $9.0 $1,214 - $1,359
151 Added 0.91%
16,702 $139,000
Q1 2023

Apr 25, 2023

SELL
$7.57 - $8.37 $227 - $251
-30 Reduced 0.18%
16,551 $134,000
Q4 2022

Jan 23, 2023

SELL
$5.96 - $8.06 $2,258 - $3,054
-379 Reduced 2.23%
16,581 $0
Q3 2022

Oct 24, 2022

BUY
$5.63 - $7.5 $95,484 - $127,200
16,960 New
16,960 $103,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Busey Wealth Management Portfolio

Follow Busey Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.